Paper · 42515014

Spatial Heterogeneity of Intratumoral Microbiota and Its Roles in Tumor-Microbiota Interactions and Therapeutic Implications.

Li L and 7 others. Pathogens, 2026. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Spatial Heterogeneity of Intratumoral Microbiota and Its Roles in Tumor-Microbiota Interactions and Therapeutic Implications. Papers, record 42515014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42515014

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Spatial Heterogeneity of Intratumoral Microbiota and Its Roles in Tumor-Microbiota Interactions and Therapeutic Implications.; PubMed
Journal: Pathogens; PubMed
Year: 2026; PubMed
Publication types: Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/42515014/; PubMed
DOI: https://doi.org/10.3390/pathogens15070687; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13414628/; PubMed
The journal: https://conductscience.org/library/journal-index/101596317; PubMed
Citations, by iCite: 1; iCite
Revised in PubMed: 2026-08-13; PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	ORCID iD
1	Li L	Li
2	Shi X	Xiaoqian
3	Liu M	Mingyang
4	Xu T	Tongzhen
5	Chen Y	Yinan
6	Wang R	Ranjiaxi
7	Zhang Q	Qiyue
8	Li D	Dan	https://orcid.org/0000-0002-5586-4055

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Tumor Microenvironment	Major topic
Microbiota	Major topic
Neoplasms	Major topic
Humans
Animals

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by
No.C2301001	Shenzhen Medical Research Fund			PubMed
2023YFC3503200、2023YFC3503205	National Key R&D Program of China			PubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References117

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	37,243,023	Engineered Phage-Based Cancer Vaccines: Current Advances and Future Directions.	Vaccines (Basel)	2023	https://conductscience.org/library/papers/37243023	PubMed
2	41,794,037	Leveraging intratumoral probiotics for pancreatic cancer immunotherapy via xenophagy.	Cell Host Microbe	2026	https://conductscience.org/library/papers/41794037	PubMed
3	40,653,189	Hypoxia and immunometabolism in the tumor microenvironment: insights into mechanisms and therapeutic potential.	Cancer Lett	2025	https://conductscience.org/library/papers/40653189	PubMed
4	40,878,391	Engineering Bacteria as Living Therapeutics in Cancer Therapy.	Adv Sci (Weinh)	2025	https://conductscience.org/library/papers/40878391	PubMed
5	38,568,096	Self-propelling bacteria-based magnetic nanoparticles (BacMags) for targeted magnetic hyperthermia therapy against hypoxic tumors.	Nanoscale	2024	https://conductscience.org/library/papers/38568096	PubMed
6	29,567,829	The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.	Cancer Discov	2018	https://conductscience.org/library/papers/29567829	PubMed
7	40,846,900	Fusobacterium nucleatum interacts with cancer-associated fibroblasts to promote colorectal cancer.	EMBO J	2025	https://conductscience.org/library/papers/40846900	PubMed
8	39,815,314	The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications.	Mol Cancer	2025	https://conductscience.org/library/papers/39815314	PubMed
9	40,016,182	Porphyromonas gingivalis potentiates stem-like properties of oral squamous cell carcinoma by modulating SCD1-dependent lipid synthesis via NOD1/KLF5 axis.	Int J Oral Sci	2025	https://conductscience.org/library/papers/40016182	PubMed
10	42,209,868	The non-bacterial oncobiome: the role of the mycobiome and virome in tumor plasticity.	J Egypt Natl Canc Inst	2026	https://conductscience.org/library/papers/42209868	PubMed

1 to 10 of 117

See all 117 references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMID	Title	Journal	Year	In Papers
42,898,931	Spatial organization of intratumoral microbiome and regional tumor immunity.	Front Immunol	2026	https://conductscience.org/library/papers/42898931

Source PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42515014

GET https://conductscience.org/api/papers/v1/42515014/references?page=2

API reference For AI assistants